Venture Capital

With a blockbuster 2025 in the books, Boston Scientific's leadership faces intense scrutiny at upcoming investor events to prove its growth is sustainable.

BridgeBio Pharma hosts a key investor webinar on its oral drug infigratinib for achondroplasia, setting the stage for crucial trial results in Q1 2026.

Bitcoin miner Bitfarms sells its last Latin American asset for $30M, pivoting fully to the booming North American AI and HPC infrastructure market.

Innocan Pharma is set to debut on the NYSE American, aiming to boost its innovative CBD drug delivery platform for non-opioid pain relief. What's next?

Singapore's Flint begins manufacturing its eco-friendly paper batteries, partnering with Logitech and Amazon to disrupt the global battery supply chain.

Neovii Pharmaceuticals names Frédéric Prince its next CEO, bringing deep oncology and gene therapy experience from Roche to steer its next growth phase.

CACI International has won a landmark contract to overhaul U.S. Space Force networks, deploying advanced software-defined tech to counter growing threats.

Distressed debt giant Silver Point Capital acquires a controlling interest in claims against bankrupt auto parts maker First Brands, a strategic move.

NAVER D2SF invests in Sorcerics, a startup whose proactive AI and on-device processing promise a smarter, safer, and more affordable smart home future.

AI drug discovery firm Insilico Medicine soars in its Hong Kong debut, the city's largest biotech IPO of 2025, validating a new tech-driven era for medicine.

Despite falling revenue and supply chain chaos, CanadaBis posts positive cash flow, signaling a disciplined new strategy for survival and sustainability.

As AI tools multiply, Cloudhands emerges with a unified platform and veteran leadership, promising to end the chaos of juggling multiple models.

Dr. Lu Xianping, crowned EY Entrepreneur Of The Year, didn't just invent new drugs; he helped reinvent China's entire pharmaceutical industry.

With industry veteran Don Cantow at the helm, Altium aims to unify electronics design on an open platform, accelerating its post-Renesas acquisition strategy.

At CES 2026, Seyond debuts its Hummingbird solid-state LiDAR with a major OEM win, challenging rivals in a race to define the future of autonomy.

A US-based Sikh group proposes a Christian homeland in India, citing a wave of anti-Christian violence that marred Christmas 2025 celebrations.

With a major funding round, Biobeat aims to replace bulky cuffs with a discreet patch, potentially revolutionizing hypertension care for millions.

Esports giant OverActive Media is raising fresh capital. Is this a strategic push into AI and esports dominance or a necessary move to shore up its finances?

Privately held MMMera hires strategic firm CND-SA to scale its Guillotine® gaming IP, a move highlighting the high-stakes game of professionalizing art.

A $300,000 financing will fuel Lomiko's push to develop battery-grade graphite in Quebec and explore a strategic antimony-gold prospect in Newfoundland.